Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Persistent Brain Fog After Mild COVID Infection Tied to CSF Markers

People with persistent cognitive changes after mild COVID had elevated levels of immune activation and immunovascular markers in their cerebrospinal fluid (CSF) 10 months after acute SARS-CoV-2 infection, a small study showed. In a late-breaking abstract presented at the American Academy of Neurology (AAN) annual meeting, Joanna Hellmuth, MD, MHS, of the University of California […]

What’s The Deal With Anxiety Rings And Do They Help Symptoms?

When it comes to managing symptoms of anxiety, there are a lot of options out there. Meditation, cognitive behavioral therapy and medication — prescribed under the guidance of a doctor, of course — are a few of them. One lesser-known method? Anxiety rings. Anxiety rings might sound high tech, but they’re really not: Most are […]

Can CV Fat Predict Cognitive Function in Women in Midlife?

The quality of cardiovascular (CV) fat in midlife women may predict their cognitive function later on in life, a researcher found. High radiodensity of perivascular adipose tissue (PVAT) around the descending aorta among women in their middle years (average age around 51) was significantly associated with worse working memory in the future (P=0.01), reported Meiyuzhen […]

COVID-19: Persistent Cognitive Effects, Uptick in Alzheimer’s Biomarkers

Cognitive impairment was correlated with persistent anosmia in older adults recovering from SARS-CoV-2 infection, initial findings from a large international consortium showed. Severity of cognitive impairment was significantly correlated with severity of olfactory dysfunction (χ2=13.82, P=0.003) but not with the severity of acute COVID-19, Gabriel de Erausquin, MD, PhD, MSc, of the University of Texas […]

Study: Exposure Therapy for Irritable Bowel Syndrome Saves Money

Including exposure therapy during internet-based cognitive behavioral therapy (ICBT) was associated with reduced treatment costs in irritable bowel syndrome (IBS), a Swedish randomized trial found. While use of ICBT with exposure initially increased direct patient costs by 20% ($213.50 per participant) versus ICBT without exposure, the added therapy led to greater reductions in societal costs […]

DBN Health News